GlassScriptPhysician profile
Celine Satija
NPI 1922452770
$2,098.92
in general payments reported to CMS, 2019-2025
17 companies · $435 in 2025
The $435 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $128 · 2022: $370 · 2023: $419 · 2024: $747 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513 · Entertainment: $88.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.11 |
| Entertainment | $88.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $840.70 | 2022-2025 | Clareon, Hydrus Microstent, Tryptyr |
| Sight Sciences, INC. | $290.97 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| New World Medical,INC. | $155.18 | 2021-2025 | Ahmed Glaucoma Valve, Clearpath, Streamline |
| Sun Pharmaceutical Industries INC. | $140.67 | 2024 | |
| Ocular Therapeutix, INC. | $123.20 | 2024 | Dextenza |
| Optos, INC. | $88.18 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $87.51 | 2022 | |
| Bausch & Lomb Americas INC. | $57.59 | 2023-2024 | Miebo, Xiidra |
| Novartis Pharmaceuticals Corporation | $57.48 | 2021-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $55.18 | 2023-2024 | Tecnis Iol, Tecnis Simplicity, Healon Duet Pro |
| Kala Pharmaceuticals, INC. | $40.01 | 2022 | |
| Abbvie INC. | $38.25 | 2022 | |
| Harrow Eye, LLC | $36.29 | 2024 | Vevye |
| Rxsight INC | $24.89 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Dompe US, INC. | $24.51 | 2024 | Oxervate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $23.22 | 2023 | Syfovre |
| Thea Pharma INC. | $15.09 | 2023 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celine Satija listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.